Vascular Surgery Products

A line of products designed to provide a gentle approach to the treatment of vascular inflammation and infections, for care, topical and systemic treatment of ‘Circulatory and microcirculatory failure, venous stasis, edema, of Ulcers and of Diabetic Foot

All products of this line are constituted by an association of active ingredients, and optimal dosages to ensure a rapid therapeutic effect.









RSS Journal of Vascular Surgery

  • Spinal Cord Ischemia and Reinterventions Following thoracic endovascular repair for Acute Type B Aortic Dissections May 7, 2024
    The technical aspects of thoracic endovascular aortic repair (TEVAR) for acute type B aortic dissection (TBAD), specifically the location of proximal seal zone (PSZ) (need to cover the left subclavian artery [LSA]), distal seal zone (DSZ) (length of aortic coverage), benefit of LSA revascularization, and prophylactic lumbar drainage are still debated. Each of these issues […]
    Helen A. Potter, Li Ding, Sukgu M. Han, Fernando Fleischman, Fred A. Weaver, Gregory A. Magee
  • Femoral Vein Translocation for Complex Hemodialysis Access May 7, 2024
    Vascular access is difficult in patients without suitable arm veins and prior graft infections. The use of femoral vein translocation to the upper extremity or contralateral lower extremity for hemodialysis access may be associated with low infection rates and high patency rates. Femoral vein translocation is used for patients without central venous occlusion who have […]
    Alexander R. Mikhail, Timothy Legare, Priscilla Tanamal, Denise Danos, Taylor Gwin, Wajeeh Irfan, Malachi Sheahan, London Guidry, Jon Schellack
  • Examining the Impact of Median Arcuate Ligament-Induced Celiac Artery Compression on Target Vessel Patency and Long-term Survival and Device Integrity in Fenestrated and Branched Endovascular Repairs May 7, 2024
    To evaluate the impact of celiac artery (CA) compression by median arcuate ligament (MAL) on technical metrics and long-term CA patency in patients with complex aortic aneurysms (cAAs) undergoing fenestrated/branched endograft repairs (f/b-EVARs).
    Jesse Manunga, Ellen Cravero, JoAnne Goldman, Larissa I. Stanberry, Elliot Stephenson, Kevin M. Harris, Nedaa Skeik
  • Real World Application of WIfI Scores in Peripheral Arterial Disease Patients May 7, 2024
    The Society for Vascular Surgery wound, ischemia, and foot infection (WIfI) classification system aims to risk stratify patients with chronic limb threatening ischemia (CLTI), predicting both amputation rates and the need for revascularization. However, real-world utilization of the system and whether it accurately predicts outcomes following open revascularization and peripheral interventions is unclear. Therefore, we […]
    Margaret E. Smith, Drew J. Braet, Jeremy Albright, Matthew A. Corriere, Nicholas H. Osborne, Peter Henke
  • Polyvascular Disease is Common in Patients Undergoing Carotid Endarterectomy and Lower Extremity Bypass and is Associated With Worse Outcomes May 7, 2024
    Polyvascular disease is strongly associated with increased risk of cardiovascular morbidity and mortality. However, its prevalence in patients undergoing carotid and lower extremity surgical revascularization and its impact on outcomes are unknown.
    Kris M. Boelitz, Alexandra Forsyth, Allison Crawford, Jessica P. Simons, Jeffrey J. Siracuse, Alik Farber, Naomi Hamburg, Robert Eberhardt, Andres Schanzer, Douglas W. Jones
  • Preoperative Risk Factors for 1-year Mortality in Patients Undergoing Fenestrated Endovascular Aortic Aneurysm Repair in the US-Aortic Research Consortium May 6, 2024
    Early survival (1-year) following elective repair of complex abdominal aortic aneurysms (AAA) or thoracoabdominal aortic aneurysms (TAAA) can be utilized as an indicator of successful repair and provides a reasonable countermeasure to the annual rupture risk based on diameter. We aimed to identify preoperative factors associated with 1-year mortality following F/BEVAR and develop a predictive […]
    C.A. Banks, Z. Novak, E.L. Spangler, A. Schanzer, M. Farber, M.P. Sweet, G. Oderich, C. Timaran, A. Lee, D. Schneider, M. Eagleton, W. Gasper, A.W. Beck
  • Endovascular therapy versus bypass for chronic limb-threatening ischemia in a real-world practice May 6, 2024
    The recent BEST-CLI study showed that bypass was superior to endovascular therapy (ET) in patients with chronic limb threatening ischemia (CLTI) deemed suitable for either approach who had an available single segment great saphenous vein (GSV). However, the superiority of bypass among those lacking GSV was not established. We aimed to examine comparative treatment outcomes […]
    Sina Zarrintan, Shima Rahgozar, Elsie G. Ross, Alik Farber, Matthew T. Menard, Michael S. Conte, Mahmoud B. Malas